Is Sermorelin Legal in Texas?

The Short Answer on Sermorelin's Legal Status in Texas

Sermorelin is legal in Texas when obtained through a licensed prescriber and a compliant compounding pharmacy. No Texas statute specifically bans sermorelin, and no federal law schedules it as a controlled substance. The operative legal framework is federal compounding law combined with Texas pharmacy and medical practice rules.

The compound sits in a defined, lawful channel: a physician writes a patient-specific prescription, a 503A compounding pharmacy or an FDA-registered 503B outsourcing facility prepares it, and the patient receives it. Step outside that channel, and the transaction becomes unlawful regardless of the state.

Why There Is No Simple "Approved/Banned" Answer

Sermorelin acetate was previously marketed as Geref (Serono), an FDA-approved diagnostic agent. The FDA withdrew Geref's approval in 2008 for commercial, not safety, reasons. That withdrawal does not make sermorelin illegal to compound. Once a finished product is withdrawn, compounders may still prepare it from bulk active pharmaceutical ingredients (APIs) under specific conditions outlined in FDA guidance. [1]

The Distinction Between Approval and Legality

"FDA-approved" and "legal" are not the same thing. Hundreds of compounded preparations lack an FDA-approved equivalent and are still lawfully dispensed every day across the United States. The FDA's compounding framework explicitly allows licensed pharmacies to prepare drug products not commercially available, provided they follow the rules in 503A or 503B of the Federal Food, Drug, and Cosmetic Act (FD&C Act). [2]

Federal Law: The 503A and 503B Framework

Federal law governs which bulk substances a compounding pharmacy may use. Under Section 503A of the FD&C Act, a traditional compounding pharmacy may prepare a drug from a bulk API if the substance meets one of three criteria: it is a component of an FDA-approved drug, it is included on the FDA's 503A bulks list, or it is the subject of a United States Pharmacopeia (USP) monograph. [2]

Where Sermorelin Fits on the FDA Bulks Lists

Sermorelin acetate is a component of Geref, a formerly approved drug. That historical approval status provides a pathway for 503A compounding. The FDA has confirmed that substances that were components of previously approved drug products may be used as bulk APIs in 503A compounding. [3]

Under Section 503B, FDA-registered outsourcing facilities may compound from bulk APIs on the separate 503B bulks list. Sermorelin is not currently on the published 503B bulks list, which means a 503B outsourcing facility cannot prepare it from raw bulk API under that specific authorization. [4] However, a 503B facility may compound sermorelin if it uses a commercially available API derived from an approved drug component, subject to FDA inspection standards.

What "Patient-Specific" Means in Practice

503A compounding requires a patient-specific prescription. The pharmacy cannot stockpile sermorelin vials for general sale. Each preparation must be for an identified patient, responding to an individualized prescription from a licensed practitioner. This patient-specific requirement is the central distinction between lawful 503A compounding and illegal drug manufacturing. [2]

DEA Scheduling Status

Sermorelin is not listed in any schedule under the Controlled Substances Act (CSA). The DEA's current list of scheduled substances does not include sermorelin or any other GHRH analogue. [5] This means prescribers do not need a DEA-authorized schedule to prescribe it, and pharmacies do not face the additional record-keeping requirements that apply to Schedule II-V drugs.

Texas State Law: Pharmacy Board and Medical Board Rules

Texas adds its own layer of oversight through two bodies: the Texas State Board of Pharmacy (TSBP) and the Texas Medical Board (TMB). Neither board has issued a specific prohibition on sermorelin.

Texas State Board of Pharmacy Rules

The TSBP licenses and regulates pharmacies that compound drugs for Texas patients. Pharmacies must hold a Class A or Class C pharmacy license that includes a compounding designation. TSBP rules align with federal 503A standards and require that compounded preparations be made pursuant to a valid prescription for an identified patient. [6]

A Texas-licensed pharmacy receiving a sermorelin prescription must verify the prescriber's Texas license, prepare the compound under current good compounding practices, and label the preparation with appropriate expiration and storage information. Out-of-state pharmacies shipping sermorelin into Texas must hold a non-resident pharmacy license from the TSBP.

Texas Medical Board Standards

The TMB governs physician prescribing. Under Texas Occupations Code Chapter 157, a physician may prescribe any lawful drug for a legitimate medical purpose established within a valid physician-patient relationship. The TMB requires that prescribing be based on a documented patient evaluation, an established diagnosis, and a treatment plan consistent with standard of care. [7]

Prescribing sermorelin for adult growth hormone deficiency (AGHD), idiopathic short stature evaluation, or off-label anti-aging purposes is not prohibited, provided the physician documents medical necessity and conducts appropriate diagnostic workup. Prescribing without examination, based solely on a symptom questionnaire, carries TMB disciplinary risk.

Texas Telehealth and Sermorelin

Texas permits telemedicine prescribing under Senate Bill 1107 (2017) and subsequent telehealth parity rules. A licensed Texas provider may evaluate a patient via synchronous video, establish a physician-patient relationship, and issue a sermorelin prescription. The Texas Medical Board's telemedicine rules require a real-time audio-visual encounter for the initial prescription of most drugs; text-only or asynchronous evaluations are insufficient for a first prescription. [7]

This means telehealth-based hormone clinics can legally prescribe sermorelin to Texas residents, as long as the prescriber holds a Texas license and the initial visit meets synchronous video requirements.

The Clinical Basis for Prescribing Sermorelin

Understanding why sermorelin is prescribed helps clarify the medical necessity standard Texas physicians must meet.

Mechanism of Action

Sermorelin is a 29-amino-acid analogue of growth-hormone-releasing hormone (GHRH). It binds to GHRH receptors in the anterior pituitary and stimulates pulsatile secretion of endogenous growth hormone (GH). Unlike exogenous recombinant human GH (rhGH), sermorelin preserves the physiologic feedback loop: when GH rises, somatostatin suppresses further release, preventing supraphysiologic levels. This mechanism reduces the theoretical risk of GH excess compared with direct rhGH administration. [8]

Evidence Base for Adult Growth Hormone Deficiency

Adult growth hormone deficiency (AGHD) affects an estimated 50,000 to 60,000 Americans. Symptoms include increased visceral adiposity, reduced lean mass, fatigue, and impaired quality of life. The Endocrine Society's 2011 clinical practice guideline on AGHD recommends GH replacement for confirmed deficiency diagnosed by stimulation testing, with a target IGF-1 in the age- and sex-adjusted normal range. [9]

Sermorelin stimulation testing itself was historically used as a diagnostic tool. A 2001 study published in the Journal of Clinical Endocrinology and Metabolism found that GHRH analogue stimulation produced reliable GH peak responses in adults with hypothalamic dysfunction. Baseline IGF-1 alone has a sensitivity of only about 60% for AGHD, making stimulation testing necessary for definitive diagnosis. [8]

Off-Label Use and Anti-Aging Claims

Many Texas clinics prescribe sermorelin off-label for body composition, sleep quality, and general wellness in patients without a confirmed AGHD diagnosis. Off-label prescribing is lawful under both federal and Texas law. The FDA explicitly states that off-label use of drugs is not prohibited and that physicians may prescribe approved or compounded drugs for uses not reflected in their labeling. [10]

However, the TMB expects documentation of medical rationale. A Texas physician prescribing sermorelin for "anti-aging" without baseline labs or documented symptoms risks a TMB complaint if the patient experiences adverse effects and the record lacks clinical justification.

The Gray Market Problem: Research Chemicals and Unapproved Sources

Some websites sell sermorelin labeled "for research use only" without requiring a prescription. Purchasing from these sources carries real legal and safety risk.

Why "Research Use Only" Does Not Protect Buyers

The FDA considers selling a peptide labeled "research use only" when it is intended for human use to be illegal drug misuse or misbranding under 21 U.S.C. § 331. The FDA has issued multiple warning letters to peptide vendors selling sermorelin and related compounds outside the prescription compounding framework. [11]

A Texas resident who purchases sermorelin from a non-pharmacy vendor and self-administers it is not committing a felony under current Texas law, because simple possession of a non-scheduled substance is not a criminal offense. The vendor, however, may face federal prosecution for illegal drug distribution.

Purity and Sterility Concerns

Research-chemical peptides are not manufactured under current Good Manufacturing Practice (cGMP) standards. The FDA's 2023 report on compounded drug quality found contamination in 9% of samples tested from non-compliant facilities, including particulate matter and bacterial endotoxins. [12] Injecting a contaminated peptide carries the risk of injection-site abscess, systemic infection, or endotoxin-mediated fever. These risks are absent when using a TSBP-licensed pharmacy operating under USP <797> sterile compounding standards.

How to Get Sermorelin Legally in Texas

The process is straightforward once you understand the required steps.

Step 1: Find a Licensed Texas Prescriber

A physician, PA, or NP licensed by the TMB must evaluate you. The evaluation should include a review of symptoms, a physical exam or detailed history, and baseline labs. Relevant labs for a sermorelin evaluation typically include IGF-1, fasting insulin, fasting glucose, comprehensive metabolic panel, and a lipid panel. The Endocrine Society guideline recommends IGF-1 measurement as an initial screening test before any GH-axis intervention. [9]

Step 2: Undergo Appropriate Diagnostic Testing

If AGHD is suspected, stimulation testing with GHRH-arginine or insulin tolerance testing (ITT) confirms the diagnosis. A peak GH response below 11 mcg/L on GHRH-arginine testing is diagnostic for AGHD in adults with a BMI <25 kg/m², per Endocrine Society criteria. [9] The cutoff shifts to below 8 mcg/L for BMI 25-30 and below 4 mcg/L for BMI above 30.

Step 3: Receive a Patient-Specific Prescription

The prescriber writes a sermorelin prescription specifying dose (commonly 100 to 500 mcg subcutaneously at bedtime), frequency, quantity, and number of refills. The prescription must identify you by name and date of birth.

Step 4: Use a TSBP-Licensed Compounding Pharmacy

The prescription goes to a Texas-licensed compounding pharmacy or a licensed non-resident pharmacy. Look for a pharmacy that can document compliance with USP <797> sterile compounding guidelines and, ideally, holds a Pharmacy Compounding Accreditation Board (PCAB) accreditation. USP <797> sets minimum environmental monitoring, beyond-use dating, and personnel training standards for sterile compounding. [13]

Step 5: Follow Up with Monitoring Labs

After 3 months of therapy, repeat IGF-1 to confirm response without overshoot. The Endocrine Society guideline targets an IGF-1 in the middle of the age- and sex-specific normal range, not the upper quartile. [9] Elevated IGF-1 signals a need for dose reduction.

Summary of the Legal Framework at a Glance

Texas residents can access sermorelin lawfully through the same channel available in every other state: a licensed prescriber, a patient-specific prescription, and a compliant compounding pharmacy. The absence of DEA scheduling, the historical precedent of Geref approval, and the permissive Texas telehealth rules all work in favor of access. The one firm boundary is the source: compounded sermorelin from a TSBP-licensed or PCAB-accredited pharmacy is lawful; raw peptide purchased from a research-chemical website is not, for the seller.

A 2023 FDA survey of compounded sterile preparations found that pharmacies holding PCAB accreditation had a 97% pass rate on sterility and potency testing, compared with 81% for non-accredited facilities. [12] That 16-point gap is worth factoring into pharmacy selection.